Ovid Therapeutics Inc. is a biopharmaceutical company. The Company is focused on developing medicines for patients and families living with epilepsies and seizure-related neurological disorders. The Company is developing OV329 a GABA-aminotransferase... Read more
MarketWatch
CNBC
CNBC
SeekingAlpha
Access detailed stock analysis from LSEG including analyst price target estimates.